NCT01933542View on ClinicalTrials.gov

The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
ChlorzoxazonePostoperative Pain
Interventions
DRUG

Placebo

Two placebo tablets identical to the chlorzoxazone tablets.

DRUG

Chlorzoxazone

Two 250 mg chlorzoxazone tablets

DRUG

Morphine

Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.

DRUG

Zofran

Zofran 4 mg iv. in case of moderate to severe nausea, supplemented by Zofran 1 mg iv. if needed

Trial Locations (1)

2600

Glostrup University Hospital, Glostrup Municipality

All Listed Sponsors
collaborator

Glostrup University Hospital, Copenhagen

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT01933542 - The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery | Biotech Hunter | Biotech Hunter